OphthalmologyNews.net

Ophthalmology Xagena

In the past decade, ophthalmologists have been prescribing nutritional supplements to be taken daily to prevent or slow vision loss from age-related macular degeneration ( AMD ). Now, using nutritiona ...


The clinical efficacy and toxicity of Amiodarone ( Cordarone ) may be determined more effectively by tissue deposition than by levels of the agent in serum. Therefore, corneal densitometry might be us ...


Primary open-angle glaucoma ( POAG ) is a blinding disease. Two important risk factors for this disease are a positive family history and elevated intraocular pressure ( IOP ), which is also highly he ...


Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibited promising activity in a proof-of-concept study when administered in intravenous ( IV ) doses to patients with active, chr ...


The purpose of a study was to evaluate the effect of monthly intravitreal Ranibizumab ( Lucentis ) on hard exudate ( HE ) area and the impact of hard exudate on visual acuity ( VA ) outcomes in diabet ...


A single-practice retrospective chart review has reported on long-term visual outcomes in patients receiving continuous fixed-interval dosing of anti-vascular endothelial growth factor ( VEGF ) treatm ...


Eylea ( Aflibercept ) injection has been recommended for approval by the European Committee for Medicinal Products for Human Use ( CHMP ) for the treatment of visual impairment due to macular edema s ...


The FDA ( Food and Drug Administration ) has accepted for priority review the supplemental biologics license application ( sBLA ) for Eylea ( Aflibercept ) injection for the treatment of diabetic reti ...


The clinical and demographic profile of uveitis-related ocular hypertension ( OHT ) was studied and risk factors predisposing to development of ocular hypertension in uveitis were evaluated. Two ...


The aim of a study was to assess the clinical response to Golimumab ( Simponi ) in patients with non-infectious uveitis from a single centre that had previously been treated with other anti-TNF-alpha ...


In September 2014, the FDA ( Food and Drug Administration ) granted Eylea ( Aflibercept ) injection Breakthrough Therapy designation for the treatment of diabetic retinopathy in patients with diabetic ...


A study has assessed the safety and efficacy of Tocilizumab ( Actemra; RoActemra ) in patients with severe and refractory non-infectious uveitis. Eight consecutive unselected patients with severe a ...


Long-term daily multivitamin supplement use may lower cataract risk in men, according to a study of nearly 15,000 male physicians published in Ophthalmology, the journal of the American Academy of Oph ...


A new study published in the Journal of the American Association for Pediatric Ophthalmology and Strabismus ( AAPOS ) suggests that the biologic agent Adalimumab ( Humira ) may be a viable treatment o ...


The aim of the GEFAL trial was to evaluate the relative efficacy and safety profile of Bevacizumab ( Avastin ) versus Ranibizumab ( Lucentis ) intravitreal injections for the treatment of neovascular ...